Table 1.
Clinical feature | Patient (proband) | Sister | Mother | Individual 15a |
---|---|---|---|---|
Age of symptom onset | 11 months | ND | NA | Unknown |
Gender | Female | Female | Female | Female |
Ethnicity | European | European | European | Unknown |
Mutation | Heterozygous c.85C>T p.Arg29Ter Maternally inherited |
Heterozygous c.85C>T p.Arg29Ter Maternally inherited |
Heterozygous c.85C>T p.Arg29Ter Uncertain inheritance |
Heterozygous c.85C>T p.Arg29Ter De novo |
Other genetic findings | None | ND | ND | Parentally inherited heterozygous VUS in ALOXE3, RAG1, and TLR1 |
Global developmental delay | +Severe | − | − | +Mild |
Seizures | + | − | − | + |
EEG abnormality | + | ND | ND | ND |
Visual impairments | − | + | − | − |
Speech delay | + | + | − | + |
Abnormal affect/emotion regulation | + | − | − | − |
Gross motor problems | − | + | − | − |
Gastrointestinal abnormalities | − | − | − | − |
ND: not described; NA: not applicable; VUS: variant of unknown significance; EEG: electroencephalography.
Individual 15 as described in Kury et al.1